ImpediMed Limited
IPDQF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.65M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $14.65 Million |
|---|---|
| Enterprise Value | $-106,135.00 |
| Earnings per Share | $-0.01 |
| Beta | 1.09 |
| Outstanding Shares | 2,241,543,369 |
Return
| Return on Equity | -473.04% |
|---|---|
| Return on Assets | -139.03% |
| Return on Invested Capital | -137.92% |
Valuation & Multiples
| P/E Ratio | -0.34 |
|---|---|
| PEG | -8.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -4.79 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$-0.00
Consensus analyst estimateRevenue Estimate
$5.78 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$6.11 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About ImpediMed Limited
66 employees
CEO: Erik Anderson
Operating as a medical software technology provider, ImpediMed Limited is responsible for the development, production, and global sales of bioimpedance spectroscopy (BIS) instruments and accompanying software solutions, serving markets i...